India looks for test kits from South Korea

South Korea is proving out to be an important source of medical supplies for India among the countries for novel coronavirus with aggressive testing and contact tracing. The Indian embassy in Seoul signed an agreement for supply of 5,00,000 rapid test kits from a South Korean company to the ICMR.

According to the agreement, the kits will be delivered in 4 separate consignments, the first of which will reach India April 30.

The procurement will help scale up the availability of tests which is a “big weapon’’ in the fight against Covid-19 said, India’s ambassador to South Korea Sripriya Ranganathan

“It’s not a buyer’s market but the goodwill which India enjoys with the South Korean government and its people has meant that the manufacturers are much more receptive to our needs and more flexible in meeting our demands.”

Ranganathan further added that, ‘all procurement is certified for export and subject to quality checks. “These have been found suitable for use by the ICMR. The company with which the embassy has signed the agreement is sourcing raw materials for production of the diagnostic testing kits from India, a collaboration described as a tribute to the special strategic partnership between the 2 countries.”

“It wasn’t that the Koreans from the start had the option of walking up to a hospital and getting themselves tested. It was also very expensive initially but they built up their capacity over a period of time by making tests available. Over 2 months, they pumped more tests into their healthcare system and spread the net wide as out agencies are doing now in India,’’ she said.

  • Related Posts

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis